Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0021289,
umls-concept:C0026626,
umls-concept:C0026809,
umls-concept:C0039195,
umls-concept:C0085358,
umls-concept:C0205263,
umls-concept:C0871261,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1704632,
umls-concept:C1706438,
umls-concept:C1706817,
umls-concept:C2698600,
umls-concept:C2911692
|
pubmed:issue |
12
|
pubmed:dateCreated |
1995-4-20
|
pubmed:abstractText |
Newborn NFS/N mice are susceptible to the neurological disease induced by infection with Cas-Br-M murine leukemia virus (Cas), and do not develop a protective cytotoxic T cell (CTL)-mediated response to Cas infection. Here we demonstrate that whole UV light-inactivated Cas (UV-Cas), inoculated in newborn NFS/N mice, induced a strong, Cas-specific CTL response detectable 2 weeks postinoculation and persisting in vivo for > or = 36 weeks. The magnitude of the UV-Cas-induced splenic CTL response, mediated by CD8+ T cells, inversely correlated with the level of proviral cas env sequences detectable in the spleen of the UV-Cas-inoculated mice, as revealed by PCR amplification of tissue DNA. The transfer of UV-Cas-primed splenocytes, with Cas-specific CTL activity, protected 100% of recipient newborn mice from the development of neurological disease induced by infection with live Cas, for more than 28 weeks, and reduced the level of viral replication in the recipients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0889-2229
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1695-702
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7888229-Animals,
pubmed-meshheading:7888229-Animals, Newborn,
pubmed-meshheading:7888229-CD8-Positive T-Lymphocytes,
pubmed-meshheading:7888229-Cytotoxicity, Immunologic,
pubmed-meshheading:7888229-Humans,
pubmed-meshheading:7888229-Infant, Newborn,
pubmed-meshheading:7888229-Leukemia Virus, Murine,
pubmed-meshheading:7888229-Mice,
pubmed-meshheading:7888229-Nervous System Diseases,
pubmed-meshheading:7888229-Retroviridae Infections,
pubmed-meshheading:7888229-Spleen,
pubmed-meshheading:7888229-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:7888229-Tumor Virus Infections,
pubmed-meshheading:7888229-Ultraviolet Rays,
pubmed-meshheading:7888229-Vaccines, Inactivated,
pubmed-meshheading:7888229-Viral Vaccines
|
pubmed:year |
1994
|
pubmed:articleTitle |
Ultraviolet-light-inactivated Cas-Br-M murine leukemia virus induces a protective CD8+ cytotoxic T lymphocyte response in newborn mice.
|
pubmed:affiliation |
Retrovirus Research Center, Veterans Affairs Medical Center, Baltimore, Maryland 21201.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|